189 related articles for article (PubMed ID: 12378619)
1. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma.
Jiang Y; Zhou XD; Liu YK; Wu X; Huang XW
World J Gastroenterol; 2002 Oct; 8(5):804-7. PubMed ID: 12378619
[TBL] [Abstract][Full Text] [Related]
2. Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China.
Cui J; Zhou XD; Liu YK; Tang ZY; Zile MH
World J Gastroenterol; 2001 Aug; 7(4):542-6. PubMed ID: 11819825
[TBL] [Abstract][Full Text] [Related]
3. Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people.
Cui J; Zhou X; Liu Y; Tang Z
J Cancer Res Clin Oncol; 2001 Sep; 127(9):577-81. PubMed ID: 11570580
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
5. [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma].
Jiao Y; Ban KC; Cao J; Yue HY; Luo Y; Su JJ
Ai Zheng; 2007 Oct; 26(10):1085-9. PubMed ID: 17927878
[TBL] [Abstract][Full Text] [Related]
6. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.
Zeng ZJ; Yang LY; Ding X; Wang W
World J Gastroenterol; 2004 Dec; 10(23):3414-8. PubMed ID: 15526358
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of RhoC gene in hepatocellular carcinoma.
Wang W; Yang LY; Yang ZL; Huang GW; Lu WQ
World J Gastroenterol; 2003 Sep; 9(9):1950-3. PubMed ID: 12970882
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma.
Ding X; Yang LY; Huang GW; Wang W; Lu WQ
World J Gastroenterol; 2004 Sep; 10(18):2735-9. PubMed ID: 15309730
[TBL] [Abstract][Full Text] [Related]
9. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
10. PIN1 gene overexpression and beta-catenin gene mutation/expression in hepatocellular carcinoma and their significance.
Wang H; Zhang J; Feng W; Zhang S; Liang H; Wang Y; Zheng Q; Li Z
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):54-7. PubMed ID: 17393110
[TBL] [Abstract][Full Text] [Related]
11. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
12. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
[TBL] [Abstract][Full Text] [Related]
15. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
Duval A; Rolland S; Tubacher E; Bui H; Thomas G; Hamelin R
Cancer Res; 2000 Jul; 60(14):3872-9. PubMed ID: 10919662
[TBL] [Abstract][Full Text] [Related]
16. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between aberrant FHIT transcripts and hepatocellular carcinoma].
Yu YC; Sun FY; Li Z; Lu SY; Teng XH
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):550-1. PubMed ID: 14552718
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Genda T; Mizokami M; Ueda R; Hirohashi S
Jpn J Cancer Res; 1999 Dec; 90(12):1301-9. PubMed ID: 10665646
[TBL] [Abstract][Full Text] [Related]
20. Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma.
Li P; Cao Y; Li Y; Zhou L; Liu X; Geng M
Int J Clin Exp Pathol; 2014; 7(6):3190-5. PubMed ID: 25031739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
